FDA Warns About Stolen Insulin

The FDA has reminded the public that stolen vials of the long-acting insulin Levemir made by Novo Nordisk still may be on the market.

Reportedly, evidence gathered to date suggests that the stolen insulin was not stored and handled properly and may be dangerous for people to use. The FDA has received multiple reports of patients who suffered an adverse event due to poor control of glucose levels after using a vial from one of the stolen lots.

FDA first alerted the public to the theft in June and reported that three lots of Levemir totaling 129,000 vials had been stolen in North Carolina. So far only about 2% of the total amount stolen has been recovered.

The Levemir insulin belong to the following lots: XZF0036; XZF0037; XZF0038.